Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2
Visualitza/Obre
Autor/a
Tort-Miró, Aida
Navas, María Jesús
Muñoz, Marta
Martín-Mur, Beatriz
Meas, Sochanwattey
Motuzova, Veronika
Chang, Chia-Yu
Gut, Marta
Esteve-Codina, Anna
Gavrilov, Boris
Liu, Lihong
Data de publicació
2024-05-09ISSN
2076-393X
Resum
African swine fever (ASF) is a deadly disease of swine currently causing a worldwide
pandemic, leading to severe economic consequences for the porcine industry. The control of disease
spread is hampered by the limitation of available effective vaccines. Live attenuated vaccines (LAVs)
are currently the most advanced vaccine prototypes, providing strong protection against ASF. However, the significant advances achieved using LAVs must be complemented with further studies to
analyze vaccine-induced immunity. Here, we characterized the onset of cross-protective immunity
triggered by the LAV candidate BA71ΔCD2. Intranasally vaccinated pigs were challenged with the
virulent Georgia 2007/1 strain at days 3, 7 and 12 postvaccination. Only the animals vaccinated 12
days before the challenge had effectively controlled infection progression, showing low virus loads,
minor clinical signs and a lack of the unbalanced inflammatory response characteristic of severe
disease. Contrarily, the animals vaccinated 3 or 7 days before the challenge just showed a minor
delay in disease progression. An analysis of the humoral response and whole blood transcriptome
signatures demonstrated that the control of infection was associated with the presence of virusspecific IgG and a cytotoxic response before the challenge. These results contribute to our understanding of protective immunity induced by LAV-based vaccines, encouraging their use in emergency responses in ASF-affected areas.
Tipus de document
Article
Versió del document
Versió publicada
Llengua
English
Matèries (CDU)
619 - Veterinària
Pàgines
21
Publicat per
MDPI
Publicat a
Vaccines
Citació
Marín-Moraleda, David, Jordana Muñoz-Basagoiti, Aida Tort-Miró, María Jesús Navas, Marta Muñoz, Enric Vidal, Àlex Cobos, et al. 2024. “Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2”. Vaccines 12 (5): 517. doi: 10.3390/vaccines12050517
Número de l'acord de la subvenció
MICINN/Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia/PID2022-136312OB-I00/ES/ /
Programa
Sanitat Animal
Aquest element apareix en la col·lecció o col·leccions següent(s)
- ARTICLES CIENTÍFICS [2802]
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by/4.0/